|Articles|August 1, 2001
- Pharmaceutical Executive-08-01-2001
- Volume 0
- Issue 0
Mergers: Big Pharma Shrinks Some
Author(s)Kevin Gopal
London-GlaxoSmithKline is proposing to cut more than 2,000 jobs from its worldwide workforce of 100,000 as it seeks to generate the promised savings from its merger.
Advertisement
Articles in this issue
almost 25 years ago
Decision Making at Digital Speedalmost 25 years ago
Generics: Streamline and Stimulatealmost 25 years ago
Grace Under Firealmost 25 years ago
Get Ready to Merge or Divergealmost 25 years ago
Pharma's Quantum Shufflealmost 25 years ago
Science-Driven MarketingAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
3
The Risks and Benefits of FDA Reviewing Real-Time Data
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5